Who invested in Omniome?
Omniome's investors include Arch, Decheng Capital, Altitude Life Science Ventures, Biomatics Capital and Nan Fung Life Sciences, and 2 more on record.
United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$60Mraised across 1 round since 2018, from 1 source
Reported by FinSMEs
From the SEC filings it signed: 5 on the team.
On the board, as filediDan S. ZabrowskiDavid S. CruikshankKim S. KamdarMichael S. Yi
Omniome's investors include Arch, Decheng Capital, Altitude Life Science Ventures, Biomatics Capital and Nan Fung Life Sciences, and 2 more on record.
Omniome has raised $60M across 1 round since 2018.
Omniome's most recent round was a Series B of $60M in Jul 2018.
Its most recent round, $60M in Jul 2018, is also its largest on record.
Omniome's first round on record, in Jul 2018, was backed by Arch, Decheng Capital and Altitude Life Science Ventures and 4 others.
Omniome's latest named round is a Series B, in Jul 2018.
Omniome is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.